Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this
BioCrystbiocryst.comBioCryst is a global biotechnology company that discovers, develops, and commercializes novel oral small molecule and injectable protein therapeutics for rare diseases, with a focus on hereditary angioedema (HAE). Founded in 1986, the company employs a structure-guided drug design approach to create first-in-class or best-in-class treatments for patients with challenging rare disease categories.
Parse Score
